BIOMAT Database Logo BIOMAT Database Logo

Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. 2020

Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore and Bethesda, MD, USA.

As perspectives on cannabis continue to shift, understanding the physiological and behavioral effects of cannabis use is of paramount importance. Previous data suggest that cannabis use influences food intake, appetite, and metabolism, yet human research in this regard remains scant. The present study investigated the effects of cannabis administration, via different routes, on peripheral concentrations of appetitive and metabolic hormones in a sample of cannabis users. This was a randomized, crossover, double-blind, placebo-controlled study. Twenty participants underwent four experimental sessions during which oral cannabis, smoked cannabis, vaporized cannabis, or placebo was administered. Active compounds contained 6.9 ± 0.95% (~50.6 mg) ∆9-tetrahydrocannabinol (THC). Repeated blood samples were obtained, and the following endocrine markers were measured: total ghrelin, acyl-ghrelin, leptin, glucagon-like peptide-1 (GLP-1), and insulin. Results showed a significant drug main effect (p = 0.001), as well as a significant drug × time-point interaction effect (p = 0.01) on insulin. The spike in blood insulin concentrations observed under the placebo condition (probably due to the intake of brownie) was blunted by cannabis administration. A significant drug main effect (p = 0.001), as well as a trend-level drug × time-point interaction effect (p = 0.08) was also detected for GLP-1, suggesting that GLP-1 concentrations were lower under cannabis, compared to the placebo condition. Finally, a significant drug main effect (p = 0.01) was found for total ghrelin, suggesting that total ghrelin concentrations during the oral cannabis session were higher than the smoked and vaporized cannabis sessions. In conclusion, cannabis administration in this study modulated blood concentrations of some appetitive and metabolic hormones, chiefly insulin, in cannabis users. Understanding the mechanisms underpinning these effects may provide additional information on the cross-talk between cannabinoids and physiological pathways related to appetite and metabolism.

UI MeSH Term Description Entries
D007753 Laboratories Facilities equipped to carry out investigative procedures. Laboratory
D002188 Cannabis The plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber. Bhang,Ganja,Hashish,Hemp,Cannabis indica,Cannabis sativa,Hemp Plant,Marihuana,Marijuana,Bhangs,Cannabi,Ganjas,Hashishs,Hemp Plants,Hemps,Plant, Hemp,Plants, Hemp
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001066 Appetite Natural recurring desire for food. Alterations may be induced by APPETITE DEPRESSANTS or APPETITE STIMULANTS. Appetite Alterations,Alteration, Appetite,Alterations, Appetite,Appetite Alteration,Appetites
D012906 Smoke Visible gaseous suspension of carbon and other particulate matter emitted from burning substances.
D013759 Dronabinol A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. THC,Tetrahydrocannabinol,delta(9)-THC,9-ene-Tetrahydrocannabinol,Marinol,Tetrahydrocannabinol, (6a-trans)-Isomer,Tetrahydrocannabinol, (6aR-cis)-Isomer,Tetrahydrocannabinol, (6aS-cis)-Isomer,Tetrahydrocannabinol, Trans-(+-)-Isomer,Tetrahydrocannabinol, Trans-Isomer,delta(1)-THC,delta(1)-Tetrahydrocannabinol,delta(9)-Tetrahydrocannabinol,9 ene Tetrahydrocannabinol,Tetrahydrocannabinol, Trans Isomer
D054439 Ghrelin A 28-amino acid, acylated, orexigenic peptide that is a ligand for GROWTH HORMONE SECRETAGOGUE RECEPTORS. Ghrelin is widely expressed but primarily in the stomach in the adults. Ghrelin acts centrally to stimulate growth hormone secretion and food intake, and peripherally to regulate energy homeostasis. Its large precursor protein, known as appetite-regulating hormone or motilin-related peptide, contains ghrelin and obestatin. Appetite-Regulating Hormone,GHRL Protein,Gastric MLTRP,Ghrelin Precursor,Ghrelin-Obestatin Preprohormone,Motilin-Related Peptide,Motilin-Related Peptide Precursor,Obestatin,PpMTLRP,Ppghrelin,Appetite Regulating Hormone,Ghrelin Obestatin Preprohormone,Motilin Related Peptide,Motilin Related Peptide Precursor,Peptide Precursor, Motilin-Related,Precursor, Ghrelin,Precursor, Motilin-Related Peptide
D018592 Cross-Over Studies Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed) Cross-Over Design,Cross-Over Trials,Crossover Design,Crossover Studies,Crossover Trials,Cross Over Design,Cross Over Studies,Cross Over Trials,Cross-Over Designs,Cross-Over Study,Crossover Designs,Crossover Study,Design, Cross-Over,Design, Crossover,Designs, Cross-Over,Designs, Crossover,Studies, Cross-Over,Studies, Crossover,Study, Cross-Over,Study, Crossover,Trial, Cross-Over,Trial, Crossover,Trials, Cross-Over,Trials, Crossover

Related Publications

Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
Impact of smoked cannabis on tobacco cigarette smoking intensity and subjective effects: A placebo-controlled, double-blind, within-subjects human laboratory study.
August 2021, Experimental and clinical psychopharmacology,
Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
June 2017, Drug testing and analysis,
Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
Ciamexone in endocrine orbitopathy. A randomized double-blind, placebo-controlled study.
January 1990, Acta endocrinologica,
Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol.
January 2022, Frontiers in pharmacology,
Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
Dose-related effects of oral acetaminophen on cold-induced pain: a double-blind, randomized, placebo-controlled trial.
March 1998, Clinical pharmacology and therapeutics,
Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial.
February 2024, medRxiv : the preprint server for health sciences,
Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study.
July 1987, Journal of the American Dental Association (1939),
Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.
April 2009, Drug and alcohol dependence,
Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.
July 2016, The international journal of neuropsychopharmacology,
Mehdi Farokhnia, and Gray R McDiarmid, and Matthew N Newmeyer, and Vikas Munjal, and Osama A Abulseoud, and Marilyn A Huestis, and Lorenzo Leggio
Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
July 2006, Metabolism: clinical and experimental,
Copied contents to your clipboard!